Bill > HB1755

This bill establishes new reporting requirements for participants in the 340B Drug Pricing Program, a federal program that allows certain healthcare organizations to purchase prescription drugs at discounted rates. Specifically, any 340B covered entity with a service address in New Hampshire must submit a comprehensive annual report to the Department of Health and Human Services and the Attorney General by April 1st each year. The report must include detailed financial information such as drug acquisition costs, payment amounts, number of prescription claims, how 340B program savings are used (e.g., for charity care), total operating costs, and charity care expenses. The bill also requires reporting on patient characteristics, including the number of low-income, financially indigent, and medically indigent patients. The Department of Health and Human Services must then prepare an aggregated report to be submitted to the legislature and posted online by November 15th. The bill includes penalties for non-compliance, with entities facing fines of $1,000 per day for late reporting, and violations can be treated as unfair trade practices. Additionally, the Director of Charitable Trusts will review the submitted data to evaluate whether entities are operating in compliance with charitable trust and nonprofit obligations, with a specific focus on collection practices and the use of 340B program savings. The bill is set to take effect on January 1, 2027.

Health and Social Services

https://gc.nh.gov/bill_Status/billinfo.aspx?id=2345&inflect=2